TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
about
Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell lineOverexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cellsOverexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaBTRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis inductionCleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosisFunctional isoforms of IkappaB kinase alpha (IKKalpha) lacking leucine zipper and helix-loop-helix domains reveal that IKKalpha and IKKbeta have different activation requirementsL-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosisA phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cellsNF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsStat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activationInteraction of TAFII105 with selected p65/RelA dimers is associated with activation of subset of NF-kappa B genesAsbestos causes translocation of p65 protein and increases NF-kB DNA binding activity in rat lung epithelial and pleural mesothelial cellsReactive oxygen species and silica-induced carcinogenesisProtein phosphatase 2A interacts with and directly dephosphorylates RelAExpression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virusNonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activationClusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cellsA splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivatorTRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activityA20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunitLIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosisTRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activationHuntingtin promotes cell survival by preventing Pak2 cleavageProtein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosisTumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivatorsInduction of a pro-apoptotic ATM-NF-kappaB pathway and its repression by ATR in response to replication stressImpaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic miceRegulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.TAFII105 mediates activation of anti-apoptotic genes by NF-kappaBc-Jun regulates cell cycle progression and apoptosis by distinct mechanismsNedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalphaNF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosisThe Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activationLymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaBIKK1-deficient mice exhibit abnormal development of skin and skeletonCD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survivalThe prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
P2860
Q21134144-87770CC7-665F-4E7D-9EA3-D80458E98A4BQ21245718-7F6299FE-1CD2-4CE5-8CAF-C87A579E0E53Q22003755-8381EE4A-9179-47D5-B1E7-C8FF49CD4F38Q22010049-AE4FE6D2-FE4E-44FB-8837-621F70AB3F66Q22010238-86C64E18-EA52-439D-9495-13B74B44EAB8Q22010633-2E27A187-71A1-4662-AA2F-5C6F74A02031Q22010649-4D89C87C-D191-42F2-9190-DBC719A1DD9FQ22253369-E012AFD7-4585-4D52-8C83-001F024BD4A5Q22253415-7226A7C9-AC86-4428-A98B-044C08639B5DQ22253428-804A04A1-EF01-432B-96AF-198506EB2D2BQ22254088-03FFA700-14D8-4F8D-B323-CDF2B3E30044Q22254226-C0B0BA33-2F16-4E85-8881-81E2A61CCCD7Q22254261-B9E04FB0-8B95-44E4-B174-2E3FDDC61EE2Q23923046-E23EED11-585B-410C-9363-8EB924AA05FBQ23923891-6281A177-C0B0-4A89-B77F-B5FAC82EED4DQ24291769-D0155C31-24A5-4EE6-8F60-7C3283709942Q24292236-678199D0-E2B4-45AD-9021-1E659EFBA69DQ24292240-00B7A6A6-FDC1-40D8-ABB9-07BDE18A9DD9Q24294824-EF9B4A9E-AB17-4F24-B521-BE047B73A897Q24295232-E5B64775-4716-42DF-8E84-9309877BDC2AQ24301176-0D9D3FDD-E46F-4A84-8A45-E330BCF3BF1DQ24304048-4A93BF5D-9C01-497B-9EC7-FE17A9C8E948Q24309145-EB7B2A11-2EA6-408E-9630-08BCEE8C8347Q24312907-21E62EAA-E218-4781-8921-153016E47A18Q24313308-F8656315-235A-4724-8B6A-AFFE1BA4C346Q24314724-736E9353-131F-4899-A17E-C454C6A4D76CQ24322824-08769EE2-EFDD-4FA7-89A1-4961767304FDQ24336072-1460C50C-0962-42A1-8179-ABDC95910E32Q24336239-DF83824C-5E5C-425D-A4DA-0025BB87A53AQ24530757-6845ACD5-C634-4C3E-BE16-74611D3EE3B4Q24532251-97628AF4-1AA8-4370-ACA3-0398F0537702Q24533311-750D01AF-DCA5-4199-A9DB-BDA1FD694EA9Q24533507-7577BB92-ADEB-48C3-94E9-2CF52502E19DQ24554289-FEB258AD-A871-470E-BFA6-5E00D3438932Q24554454-9CC1B66D-F252-481E-99E1-78BFC1F59FA1Q24554457-F885186F-30E3-4ADE-B441-98C5ECED9D85Q24564927-F6DB1F86-B988-45F9-979B-4DA87B4539D4Q24604269-C33CD78B-2E4A-40C9-B09C-B4167960CD9FQ24605401-FB2EF5C2-F137-4682-975C-3B98DB0C5677Q24608044-C00BDE2E-7339-4232-99E8-F97737E95EE5
P2860
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@ast
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@en
type
label
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@ast
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@en
prefLabel
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@ast
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@en
P2093
P3181
P1433
P1476
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
@en
P2093
P3181
P356
10.1126/SCIENCE.274.5288.784
P407
P577
1996-11-01T00:00:00Z